SHARE:  
Join Our Email List
NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE


NEWS, EVENTS, and DEADLINES
November 11, 2021
Upcoming NJ ACTS and Rutgers Events

The 4 Pillars of Successful Mentorship

Good Communication, Aligning Expectations, Fostering Independence, and Promoting Professional Development

presented by:

M. Maral Mouradian, MD
Vice Chancellor for Faculty Development

Anita Siu, PharmD
Clinical Professor,
Director of Faculty Mentoring
Ernest Mario School of Pharmacy

Andrew Gow, PhD
Professor
Ernest Mario School of Pharmacy


November 16, 2021
12 - 1:30 pm

NJ ACTS Workforce Core
Professional Training Series

Communicating Your Translational Science:
Focus on a Clear Message
Lauren Aleksunes, PharmD, Phd
NJ ACTS Workforce Development Core Lead
Professor, Pharmacology and Toxicology Rutgers University

Getting your research out to the general and scientific communities requires an ability to quickly distill the “what” and “why” of your findings. During this interactive session, participants will practice their skills in communicating science. We will also review common pitfalls and how to address them.

November 16, 2021
5 - 6:30 pm

NJ ACTS Regulatory Core
Clinical Research Management
Collaborative Training Series
Regulatory Requirements for the Academic Researcher

Participants will learn:
  • An overview of regulatory requirements for clinical research from beginning to end
  • Study start up, conduct, and close out interactions
  • Important documentation and applications

Speakers
Lisa Cooper, PhD, RAC
Assistant Professor, MS Clinical Research Management
Anthony Gonzalez, MS
Manager, Quality Assurance & Quality Control
Farah Anwar, BA
Clinical Trials Office Regulatory Affairs Manager

November 17, 2021
1 - 2:30 pm

Research Resources Workshop
Wednesday Series

Rutgers Research Innovation: From Idea to Impact
Tatiana Litvin-Vechnyak, PhD
Associate Vice President
Innovation Ventures


Staffed by scientists and IP experts with industry experience, the Innovation Ventures team is dedicated to transforming research at Rutgers into products, services, and partnerships for the public good, generating value for the University and New Jersey. As your partner, the team will guide your research from proof of concept through patenting, licensing and commercialization. 

November 17, 2021
4 - 5 pm
...and More Events of Interest

University of North Carolina Clinical Science Institute is hosting the
TL1 William Schnaper Visiting Scientist Program Event


Technological solutions to therapeutic challenges in stroke rehabilitation

Alexander Brunfeldt, PhD Post Doctoral Fellow
Georgetown University Medical Center, Rehabilitation Medicine

November 12, 2021
9:30 am

Road to Commercialization Symposium Series
presented by TechAdvance® & HealthAdvance®
Attract and Maintain Industry Interest in Your Innovation

This Symposium will examine the importance of understanding market needs and ways to engage industry partners and investors to draw and sustain their interest in your technology. It will also provide critical information on Rutgers resources to protect, develop and market innovations.

featured guests:

John Currie, MBA (Keynote Speaker)
Principal & Founder, Iterate Ventures

German Drazer, PHD (Panelist)
Professor, Rutgers School of Engineering


November 18, 2021
9:30 am - 12:30 pm
GRANT OPPORTUNITIES
RADx-UP Coordination and Data Collection Center Grants Available

To further support communities across the nation who are confronting COVID-19, the RADx-UP Coordination and Data Collection Center (CDCC) is soliciting applications for two kinds of awards:

The RADx-UP CDCC Rapid Research Pilot Program provides $200,000 in direct costs to support the implementation of novel or emerging testing technologies in communities. This opportunity is open to universities and non-profits both within and outside of the RADx-UP network.

The RADx-UP CDCC Community Collaboration Mini-Grant Program provides $50,000 for direct costs and is open to community-serving organizations, faith-based organizations, and tribal nations and organizations to help advance capacity, training, support, and community experience with COVID-19 testing initiatives.

Letter of Interest due: November 19, 2021
Full application due: December 10, 2021

Pfizer Announces a Quality Improvement Grant RFP
Equity in Access to Rare Disease Clinical Trials

Area of Interest: Projects that will be considered for Pfizer support will focus on supporting initiatives to improve equity in access to rare disease clinical trials. Projects may focus on one or multiple rare disease areas. It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Award: Individual projects requesting up to $50,000 will be considered. The estimated total available budget related to this RFP is $150,000.


Application Due: December 2, 2021
‌
DEADLINES

  • RADx-UP Coordination and Data Collection Center Grants (See Above in Grant Opportunities) Letter of Interest due 11/19
NJ ACTS Publications
Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: a Retrospective Cohort Study. Hong, Thomas S.; Briscese, Kelsey; Yuan, Marshall; Deshpande, Kiran; Aleksunes, Lauren M.; et al. Antimicrobial Agents and Chemotherapy. 2021 Aug 17;65(9):e0046221. Epub 2021 Aug 17.
In Case You Missed IT


NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
Components